Fig. 3From: Low-dose brachytherapy for early stage penile cancer: a 20-year single-institution study (73 patients) a) Disease free survival depending on nodal (blue line for patients node positive disease and green for patients node negative disease). b) Regional disease free survival, blue line for patients without node disease and green one for node negative diseaseBack to article page